Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications

Extended-spectrum β-lactamases (ESBL)-producing organisms currently represent a major health problem. Although recently published guidelines still consider carbapenems as the treatment of choice for ESBL-producing infections, it is necessary to find non-carbapenem β-lactams as alternatives to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Maseda, Emilio, de la Rica, Alejandro Suárez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2022
Materias:
Update on antimicrobial pharmacotherapy against multidrug-resistant Gram-negative bacilli
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717462/
https://www.ncbi.nlm.nih.gov/pubmed/36285857
http://dx.doi.org/10.37201/req/s03.10.2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717462/
https://www.ncbi.nlm.nih.gov/pubmed/36285857
http://dx.doi.org/10.37201/req/s03.10.2022

Ejemplares similares